Prodia | $15,000,000 | (Jul 3, 2024)
BoldHue, Inc. | $3,400,000 | (Jul 3, 2024)
Redactive | $7,500,000 | (Jul 3, 2024)
MEDGENOME
United States
- Foster City, California
- 03/09/2022
- Unknown
- $50,000,000
MedGenome is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Our powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies.
Our unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare.
MedGenome Inc. has its Corporate Headquarters and a Next Generation Sequencing (NGS) lab in Foster City, California, US.
MedGenome Labs is the market leader for genetic diagnostic testing in India and South Asia. We deliver AI-driven and Validated Genetic testing solutions through new-age proprietary tools and technologies to empower the Clinicians for better management of disease cohorts in rare inherited diseases, reproductive genetics, cancer, eye & neurological disorders, diabetes, cardiovascular diseases and more.
Our Genetic Reference Lab at Bangalore is the only CAP accredited lab in South-East Asia, that offers over 1300 genetic tests across different disease areas such as Oncology, Neurology, Cardiology, Ophthalmology and Rare diseases.
MedGenome is the only NGS facility in the country to be validated and verified to run the highly accurate and comprehensive non-invasive prenatal test (Panorama). Our dedicated team of over 700 biologists, bioinformaticians and statisticians analyze genomics data to empower Clinicians and Patients and also enable research projects by global pharma and biotech.
MedGenome - Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions.
- Industry Biotechnology Research
- Website https://diagnostics.medgenome.com/
- LinkedIn https://www.linkedin.com/company/medgenomelabs/
Related People
Mahesh PratapneniCo Founder
India -
Bengaluru, Karnataka
Mahesh (Peema) is an investor, founder, and strategist in the Indian life sciences and technology sectors. He is known for building outstanding global teams, differentiated strategies, and successful exits. He currently serves as Executive Director of MedGenome and is on the boards of AgriGenome Labs, Saksin Life Sciences, Theragen, and Emerge Biologics. Mahesh earned his undergraduate degree in electronics and communications from IIT Madras, and his MBA from IIM Calcutta.
Vida Global | $3,000,000 | (Jul 3, 2024)
Steep | $4,303,680 | (Jul 3, 2024)
Cluby | $3,117,935 | (Jul 3, 2024)
Watchyourhealth.com | $5,000,000 | (Jul 3, 2024)
Tembo(US) | $14,000,000 | (Jul 3, 2024)
Wify Technologies | $2,993,443 | (Jul 2, 2024)
Blueroomcare Business | Undisclosed Amount | (Jul 2, 2024)
Comet(INDIA) | $5,000,000 | (Jul 2, 2024)
Cautio | $778,300 | (Jul 2, 2024)